FindMyRecallSubscribe
Class I: serious health riskOngoing

Meridian Medical Technologies a Pfizer EpiPen 2-Pak Recall

EpiPen 2-Pak (Epinephrine) Auto-Injectors 0

Meridian Medical Technologies a Pfizer Company · Brentwood, MO

Risk level
Class I
Reported by FDA
May 10, 2017
Recall ID
D-0690-2017
Check your lot numberHow we source this data

Summary

Meridian Medical Technologies a Pfizer recalled EpiPen 2-Pak starting Mar 12, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0690-2017 on May 10, 2017. Reason: Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication. Status: Ongoing.

Why it was recalled

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Product description

EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.

Lot numbers, UPCs & expiration codes

US: lot 5GM631, exp. April 2017; lot 5GM640, exp. May 2017; lot 6GM072, exp. Sep 2017; lot 6GM082, exp. Sep 2017; lot 6GM088, exp. Oct 2017; lot 6GM087, exp. Oct 2017; lot 6GM198, exp. Oct 2017; lot 6GM081, exp. Sep 2017; lot 6GM091, exp. Oct 2017; lot 6GM199, exp. Oct 2017: INTERNATIONAL: lot 5FA665, exp. April 2017; lot 5GU763, exp. May 2017; lot 6FA293, exp. Oct 2017; lot 6FA292, exp. Oct 2017; lot 6GH294, exp. Oct 2017.

Where it was sold

Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0690-2017
Classification
Class I
Status
Ongoing
Recall initiated
Mar 12, 2017
FDA report date
May 10, 2017
Quantity
373,960 2-paks (U.S.) ; 331,738 auto-injectors (O.U.S.)
Recall type
Voluntary: Firm initiated
Recalling firm
Meridian Medical Technologies a Pfizer Company

Original FDA data

Every field from FDA enforcement report D-0690-2017, exactly as published.

Show all FDA fields
City
Brentwood
State
MO
Status
Ongoing
Country
United States
Event ID
76789
Address
2555 Hermelin Dr
Code information
US: lot 5GM631, exp. April 2017; lot 5GM640, exp. May 2017; lot 6GM072, exp. Sep 2017; lot 6GM082, exp. Sep 2017; lot 6GM088, exp. Oct 2017; lot 6GM087, exp. Oct 2017; lot 6GM198, exp. Oct 2017; lot 6GM081, exp. Sep 2017; lot 6GM091, exp. Oct 2017; lot 6GM199, exp. Oct 2017: INTERNATIONAL: lot 5FA665, exp. April 2017; lot 5GU763, exp. May 2017; lot 6FA293, exp. Oct 2017; lot 6FA292, exp. Oct 2017; lot 6GH294, exp. Oct 2017.
Postal code
63144-2504
Report date
May 10, 2017
Product type
Drugs
Recall number
D-0690-2017
Classification
Class I
Recalling firm
Meridian Medical Technologies a Pfizer Company
Product quantity
373,960 2-paks (U.S.) ; 331,738 auto-injectors (O.U.S.)
Reason for recall
Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
Voluntary / mandated
Voluntary: Firm initiated
Product description
EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.
Distribution pattern
Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.
Recall initiation date
Mar 12, 2017
Initial firm notification
Press Release
Center classification date
Apr 28, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0690-2017, published May 10, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls